The global generic drug market is projected to grow from USD 519.11 billion in 2025 to USD 926.54 billion by 2034, at a compound annual growth rate (CAGR) of 6.55%. This growth is driven by increasing demand for cost-effective medicines amid rising chronic diseases worldwide and the comparable efficacy of generic drugs to branded ones. North America leads the market due to its large elderly population and healthcare infrastructure, while Asia-Pacific and Europe also show strong demand. Challenges include limited awareness and availability in rural areas, but ongoing research and development offer growth opportunities.
Ether's price increased by 3% recently, driven by the growth of tokenization and the launch of Robinhood Chain, which has attracted $106 million in deposits and expanded tokenized stock access to 120 countries. Ethereum holds 47% of the real-world as...
Ethena (ENA) has gained 14.11% since early July, reclaiming short-term resistance at $0.08, helped by strong user deposits via Robinhood Earn. However, the token remains down 94% from its all-time high and faces a bearish long-term trend with key res...
The BIP-110 proposal aims to temporarily restrict non-financial data on the Bitcoin blockchain to refocus it on payments. Despite significant debate, miner support remains below 1%, with major figures like Michael Saylor and Adam Back opposing it. Th...
Bitcoin peaked at $126,000 in October 2025 before dropping over 30% to around $80,000 by December. Crypto market maker Keyrock linked this decline to a liquidity signal based on net U.S. Treasury bill issuance, showing an 8-month lag between Treasury...
Bitcoin Improvement Proposal 110 (BIP 110), which aims to limit certain non-financial transactions on the Bitcoin blockchain, faces opposition from key figures Adam Back and Michael Saylor. They argue that BIP 110 conflicts with Bitcoin's core princi...
